Thermo Fisher Scientific Inc.(TMO)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Diagnostics & Research
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Latest News & Analysis

Thermo Fisher Scientific's Krios 5 Cryo-TEM: Revolutionizing structural biology and biopharma research. See advancements in cryo-electron microscopy, sustainability, and semiconductor analysis. Thermo Fisher Scientific stock analysis.
Apr 4, 2025

Thermo Fisher Scientific: Krios 5 Cryo-TEM, Sustainability, and Market Impact

Thermo Fisher Scientific (TMO) innovates with Krios 5 Cryo-TEM, sustainable solutions, and semiconductor analysis, impacting market position and investor expectations.

Read more →
Thermo Fisher Scientific: Innovation, acquisitions, and market impact on Thermo Fisher Scientific (TMO) stock in 2025. Financial analysis, growth strategy, and investment insights.
Mar 27, 2025

Thermo Fisher Scientific (TMO): Growth, Acquisitions, and Market Impact

Thermo Fisher Scientific strategically navigates growth through innovation, acquisitions, and collaborations, bolstering its life sciences leadership despite 'weak guidance'.

Read more →
Thermo Fisher Scientific: Innovations in Semiconductor Analysis and Bioproduction Driving Growth
Mar 20, 2025

Thermo Fisher Scientific: Vulcan Lab, Solventum Acquisition & Market Impact

Thermo Fisher Scientific expands with Vulcan Lab and Solventum acquisition, showcasing financial strength and shareholder commitment amidst sector challenges.

Read more →
Thermo Fisher Scientific: Strategic moves in semiconductor analysis, biopharma, and R&D driving growth, dividend and long-term shareholder value.
Mar 18, 2025

Thermo Fisher Scientific: Innovation, Acquisitions, and Market Impact

Thermo Fisher strategically advances in semiconductor analysis and biopharma. R&D, debt management, and clinical research expansion position TMO for sustained growth.

Read more →
Thermo Fisher Scientific strategic growth: Financial analysis, acquisitions, and innovation driving TMO's market leadership in life sciences. #ThermoFisher #LifeSciences #InvestmentAnalysis
Mar 7, 2025

Thermo Fisher Scientific (TMO): Growth Strategy, Market Impact

Thermo Fisher Scientific (TMO) navigates growth through strategic acquisitions, innovation, and shareholder returns. Q4 and FY24 results exceed expectations.

Read more →
Thermo Fisher Scientific: Intraday Market Analysis, Strategic Initiatives, and Financial Performance - Insights for Investors.
Mar 5, 2025

Thermo Fisher Scientific: Intraday Strategic Snapshot

On March 5, 2025, Thermo Fisher Scientific Inc. demonstrates strategic acquisitions, robust financial performance, and steady intraday momentum.

Read more →
Thermo Fisher Scientific: Acquisitions, Clinical Registry, and Strategic Growth analysis. Explore TMO's market expansion, Solventum acquisition, CorEvitas SLE Registry, and dividend increase.
Feb 28, 2025

Thermo Fisher Scientific: Acquisition, Clinical Registry, and Growth

Thermo Fisher Scientific is strategically expanding through acquisitions and clinical registries, positioning itself for continued growth. Read our analysis.

Read more →
Thermo Fisher Scientific strategic moves: acquisitions, innovation, and shareholder value analysis.
Feb 27, 2025

Thermo Fisher Scientific: Strategic Acquisition, Innovation, and Value

Thermo Fisher Scientific (TMO) is expanding through strategic acquisitions, innovation, and shareholder value initiatives, positioning it for future growth.

Read more →
Thermo Fisher Scientific: Strategic acquisitions, innovation, and market expansion driving growth.
Feb 26, 2025

Thermo Fisher Scientific: Strategic Acquisitions, Innovation, and Market Expansion

Thermo Fisher Scientific expands capabilities via strategic acquisitions, innovation, and increased shareholder value. A deep dive into recent developments and market impacts.

Read more →
Thermo Fisher Scientific: Acquisition, market growth, and financial analysis of TMO. Insights into strategic expansions, Solventum acquisition, diagnostics, UV sensor market, and dividend increase.
Feb 25, 2025

Thermo Fisher Scientific: Acquisition, Growth, and Market Outlook

Thermo Fisher Scientific expands bioproduction with Solventum acquisition, CEO presents at TD Cowen, and capitalizes on molecular diagnostics growth trends.

Read more →
Thermo Fisher Scientific: Developments, Market Trends, and Stock Analysis in 2025. Explore dividend increase, new imaging system, and market opportunities.
Feb 24, 2025

Thermo Fisher Scientific: Developments and Market Trends in 2025

Thermo Fisher Scientific is navigating growth through strategic initiatives and market expansion, signaling a strong outlook for 2025 and beyond.

Read more →
Thermo Fisher Scientific: advancements in diagnostics, dividends, and spatial imaging, driving growth in life sciences. TMO stock analysis.
Feb 21, 2025

Thermo Fisher Scientific: Dividend, Director & Innovation Update

A dividend hike, board appointment, and product launches signal robust growth for Thermo Fisher Scientific.

Read more →
Scientist using a high-tech microscope in a modern laboratory.
Feb 18, 2025

Thermo Fisher Scientific Advances Diagnostics and Spatial Imaging Amidst Market Growth

Intraday update for Tuesday, February 18, 2025 on Thermo Fisher Scientific, highlighting new product launches, market growth forecasts and competitive insights.

Read more →
Thermo Fisher Scientific logo on a white background
Feb 18, 2025

Thermo Fisher Scientific: Driving Growth Through Innovation

This in-depth analysis details Thermo Fisher Scientific’s strong Q4 2024 results, product innovations, and strategic market expansion across key sectors.

Read more →